Fig. 4

miR-29b deficiency altered the metastasis ability of H460 cells. a, In Matrigel invasion and transwell migration assay, LV-miR-29b inhibitor infected H460 cells vs NC infected cells in a 200× light scope after crystal violet staining. Cells were counted in a light scope in four random views. b, miR-29b inhibitor increased cellular proliferation ability in H460 cells by CCK8 assay. *P < 0.05, **P < 0.01, compared with blank and NC groups. c, Photographs of subcutaneous tumors of mice injected with H460 cells that infected with LV-miR-29b inhibitor compared to NC infected cells treatment. d, Subcutaneous tumors growth curves of each group after injection. **P < 0.01, compared with blank and NC groups